1. SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infection
- Author
-
Eva A.M. Baerends, Astrid K. Hvidt, Joanne Reekie, Ole S. Søgaard, Nina B. Stærke, Dorthe Raben, Henrik Nielsen, Kristine T. Petersen, Maria R. Juhl, Isik S. Johansen, Susan O. Lindvig, Lone W. Madsen, Lothar Wiese, Lene S. Knudsen, Mette B. Iversen, Thomas Benfield, Kasper K. Iversen, Sidsel D. Andersen, Anna K. Juhl, Lisa L. Dietz, Signe R. Andreasen, Thea K. Fischer, Christian Erikstrup, Palle Valentiner-Branth, Jens Lundgren, Lars Østergaard, Martin Tolstrup, J. Lundgren, L. Østergaard, T. Benfield, L. Krohn-Dehli, D.K. Petersen, K. Fogh, E. Højmark, K.K. Iversen, P. Bek, V. Klastrup, F. Larsen, S.H. Rasmussen, M.H. Schleimann, S. Schieber, N.B. Stærke, A. Søndergaard, B. Tarp, M. Tousgaard, Y. Yehdego, J. Bodilsen, H. Nielsen, K.T. Petersen, M. Ruwald, R.K. Thisted, S.F. Caspersen, M. Iversen, L.S. Knudsen, J.L. Meyerhoff, L.G. Sander, L. Wiese, C. Abildgaard, I.K. Holden, N.E. Johansen, I.S. Johansen, L. Larsen, S.O. Lindvig, L.W. Madsen, A. Øvrehus, N.A. Kruse, H. Lomholdt, T.G. Krause, P. Valentiner-Branth, B. Søborg, T.K. Fischer, C. Erikstrup, S.R. Ostrowski, M. Tolstrup, O.S. Søgaard, D. Raben, E. Jylling, D. Hougaard, S.D. Andersen, K. Lykkegaard, S.R. Andreasen, E. Baerends, L.L. Dietz, A.K. Hvidt, A.K. Juhl, R. Olesen, K.K. Andersen, W. Bannister, C. Bjernved, T.W. Elsing, F.V. Esmann, M.A. Ghafari, E. Gravholdt, S.F. Jakobsen, M.L. Jakobsen, C.M. Jensen, T.Ø. Jensen, D. Kristensen, L.R. Kumar, C. Matthews, N. Normand, C. Olsson, J. Reekie, A. Traytel, T. Weide, A.M. Hvas, and H. Støvring
- Subjects
Immunology ,Molecular medicine ,Immune response ,Science - Abstract
Summary: SARS-CoV-2 Omicron quickly spread globally, also in regions with high vaccination coverage, emphasizing the importance of exploring the immunological requirements for protection against Omicron breakthrough infection.The test-negative matched case-control study (N = 964) characterized Omicron breakthrough infections in triple-vaccinated individuals from the ENFORCE cohort. Within 60 days before a PCR test spike-specific IgG levels were significantly lower in cases compared to controls (GMR [95% CI] for BA.2: 0.83 [0.73–0.95], p = 0.006). Multivariable logistic regression showed significant associations between high antibody levels and lower odds of infection (aOR [95% CI] for BA.2 spike-specific IgG: 0.65 [0.48–0.88], p = 0.006 and BA.2 ACE2-blocking antibodies: 0.46 [0.30–0.69], p = 0.0002). A sex-stratified analysis showed more pronounced associations for females than males.High levels of vaccine-induced antibodies provide partial protection against Omicron breakthrough infections. This is important knowledge to further characterize a threshold for protection against new variants and to estimate the necessity and timing of booster vaccination.
- Published
- 2023
- Full Text
- View/download PDF